Market Cap 19.71M
Revenue (ttm) 0.00
Net Income (ttm) -26.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 114,100
Avg Vol 179,416
Day's Range N/A - N/A
Shares Out 6.40M
Stochastic %K 7%
Beta 0.45
Analysts Strong Sell
Price Target $21.75

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 571 1811
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
FickleFin
FickleFin Sep. 3 at 11:50 AM
$QNTM $GNS $GME Quantum BioPharma plans to VOLUNTARILY DELIST its Class B subordinate voting shares from the Canadian Securities Exchange, while maintaining listings on Nasdaq, the Frankfurt Stock Exchange and Upstream. **The company cites low trading volumes in Canada and the costs and regulatory burden of a dual listing as reasons to consolidate trading on Nasdaq, which it expects could support improved long-term liquidity. 🤡🥴
0 · Reply
FickleFin
FickleFin Sep. 3 at 11:44 AM
$QNTM $17,243,174 ATM is still active. Hence why dorkus is pumping shit stock after getting fired then rehired then fired then ignored then hired again. Leading new investors to the slaughterhouse... 🤡🥴
0 · Reply
deedee12
deedee12 Sep. 2 at 1:58 AM
$QNTM 👎🏼👎🏼👎🏼👎🏼
0 · Reply
focafoca99
focafoca99 Sep. 2 at 12:58 AM
$QNTM has applied to voluntarily delist its Class B shares from the Canadian Securities Exchange.
0 · Reply
Merlintrader
Merlintrader Sep. 1 at 12:41 PM
$QNTM Quantum BioPharma ($QNTM) Stock Hub 2026: FDA Cleared Lucid-MS for Phase 2 and Q2 Strengthened Equity and Liquidity https://www.merlintrader.com/quantum-biopharma-stock-hub/
0 · Reply
RollingPins
RollingPins Aug. 31 at 8:31 PM
$QNTM more
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 31 at 7:56 PM
NetworkNewsBreaks – $QNTM $QNTM.CN Draws ‘Buy’ Rating on Lucid-MS Potential https://ibn.fm/80kGB
0 · Reply
RollingPins
RollingPins Aug. 31 at 4:39 AM
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 9:08 PM
$QNTM Quantum BioPharma Ltd. (NASDAQ: QNTM) a small-cap biotech developing drug candidates including Lucid-MS…
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:58 PM
InvestorNewsBreaks – $QNTM $QNTM Moves Myelin-Protecting MS Therapy to Phase 2 Development https://ibn.fm/1H78r
0 · Reply
Latest News on QNTM
Quantum Group initiated with a Buy at Rodman & Renshaw

2026-08-31T11:10:12.000Z - 3 days ago

Quantum Group initiated with a Buy at Rodman & Renshaw


Quantum Biopharma Provides Corporate Update

Fri, 21 Aug 2026 19:00:00 -0400 - 13 days ago

Quantum Biopharma Provides Corporate Update


Quantum BioPharma Announces Closing of Debt Settlement

Thu, 30 Jul 2026 00:18:00 -0400 - 5 weeks ago

Quantum BioPharma Announces Closing of Debt Settlement


Quantum BioPharma Announces Intention to Settle Debt

Mon, 20 Jul 2026 19:00:00 -0400 - 6 weeks ago

Quantum BioPharma Announces Intention to Settle Debt


Quantum BioPharma Provides Corporate Update

Tue, 07 Jul 2026 19:00:00 -0400 - 1 month ago

Quantum BioPharma Provides Corporate Update


Quantum BioPharma Provides Corporate Update

Mon, 01 Jun 2026 19:30:00 -0400 - 3 months ago

Quantum BioPharma Provides Corporate Update


Quantum BioPharma Provides Corporate Update

Mon, 27 Apr 2026 19:45:00 -0400 - 4 months ago

Quantum BioPharma Provides Corporate Update


Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 19:30:00 -0400 - 5 months ago

Quantum Biopharma Provides Corporate Update


Quantum BioPharma Provides Corporate Update

Wed, 11 Mar 2026 19:55:00 -0400 - 5 months ago

Quantum BioPharma Provides Corporate Update


Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:12:42.000Z - 10 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year


Quantum BioPharma sees cash runway beyond March 2027

2025-11-07T12:11:35.000Z - 10 months ago

Quantum BioPharma sees cash runway beyond March 2027


Quantum BioPharma Ltd. Provides Corporate Update

Oct 31, 2025, 7:51 PM EDT - 10 months ago

Quantum BioPharma Ltd. Provides Corporate Update


Quantum BioPharma Ltd. Announces Corporate Updates

Oct 29, 2025, 9:00 PM EDT - 10 months ago

Quantum BioPharma Ltd. Announces Corporate Updates


Quantum BioPharma Announces Corporate Updates

Sep 26, 2025, 8:00 PM EDT - 11 months ago

Quantum BioPharma Announces Corporate Updates


FickleFin
FickleFin Sep. 3 at 11:50 AM
$QNTM $GNS $GME Quantum BioPharma plans to VOLUNTARILY DELIST its Class B subordinate voting shares from the Canadian Securities Exchange, while maintaining listings on Nasdaq, the Frankfurt Stock Exchange and Upstream. **The company cites low trading volumes in Canada and the costs and regulatory burden of a dual listing as reasons to consolidate trading on Nasdaq, which it expects could support improved long-term liquidity. 🤡🥴
0 · Reply
FickleFin
FickleFin Sep. 3 at 11:44 AM
$QNTM $17,243,174 ATM is still active. Hence why dorkus is pumping shit stock after getting fired then rehired then fired then ignored then hired again. Leading new investors to the slaughterhouse... 🤡🥴
0 · Reply
deedee12
deedee12 Sep. 2 at 1:58 AM
$QNTM 👎🏼👎🏼👎🏼👎🏼
0 · Reply
focafoca99
focafoca99 Sep. 2 at 12:58 AM
$QNTM has applied to voluntarily delist its Class B shares from the Canadian Securities Exchange.
0 · Reply
Merlintrader
Merlintrader Sep. 1 at 12:41 PM
$QNTM Quantum BioPharma ($QNTM) Stock Hub 2026: FDA Cleared Lucid-MS for Phase 2 and Q2 Strengthened Equity and Liquidity https://www.merlintrader.com/quantum-biopharma-stock-hub/
0 · Reply
RollingPins
RollingPins Aug. 31 at 8:31 PM
$QNTM more
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 31 at 7:56 PM
NetworkNewsBreaks – $QNTM $QNTM.CN Draws ‘Buy’ Rating on Lucid-MS Potential https://ibn.fm/80kGB
0 · Reply
RollingPins
RollingPins Aug. 31 at 4:39 AM
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 9:08 PM
$QNTM Quantum BioPharma Ltd. (NASDAQ: QNTM) a small-cap biotech developing drug candidates including Lucid-MS…
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 27 at 7:58 PM
InvestorNewsBreaks – $QNTM $QNTM Moves Myelin-Protecting MS Therapy to Phase 2 Development https://ibn.fm/1H78r
0 · Reply
nopennys
nopennys Aug. 26 at 8:14 PM
$QNTM $GNS $CYCU 🤡 told you
0 · Reply
Mark_Venture
Mark_Venture Aug. 26 at 12:03 AM
$QNTM is about to start a phase 2 trial of their drug that is designed to do something totally unprecedented, which is to protect and regrow myelin in MS patients. This would meet a huge, unmet need. I spoke with Zeeshan again today, and he told me there will be 8 trial locations here in the US. I'm hoping one of them is close to Los Angeles.
1 · Reply
FickleFin
FickleFin Aug. 24 at 2:43 PM
$QNTM $GME $GNS . Always paying themselves before finishing anything.
0 · Reply
FickleFin
FickleFin Aug. 22 at 11:06 AM
$QNTM $GNS $GME $NWBO $MMTLP 🥴🥴🥴
1 · Reply
Gentleman4599
Gentleman4599 Aug. 22 at 4:49 AM
0 · Reply
Rambler1111
Rambler1111 Aug. 22 at 12:20 AM
$QNTM not really that much of an update today. Whatever!!!
0 · Reply
Merlintrader
Merlintrader Aug. 20 at 12:27 PM
$QNTM The interim financials for the six months to June 30, filed on August 13, put 3.65 million dollars of cash next to 5.89 million dollars of digital assets: the crypto position on the balance sheet is larger than the cash position. Total liabilities were 8.30 million, including 2.23 million of warrant liability and 1.73 million of derivative liabilities. Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/quantum-biopharma-stock-hub/?utm_source=stocktwits&utm_medium=social&utm_campaign=giro-20ago2026
0 · Reply
James23db
James23db Aug. 19 at 7:42 PM
$QNTM manipulated on both sides of the coin
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 19 at 7:17 PM
$QNTM Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves https://ibn.fm/syxOj
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 19 at 5:15 PM
BioMedNewsBreaks — $QNTM $QNTM.CN Explores Myelin Protection as New Focus in MS Treatment https://ibn.fm/4ddys
0 · Reply
FickleFin
FickleFin Aug. 19 at 1:41 PM
$QNTM $GNS $GME $NWBO $MMTLP exit liquidity is key. 😉😄
0 · Reply
MM1968
MM1968 Aug. 19 at 11:06 AM
$GNS $MMTLP $NWBO $QNTM We will see. https://x.com/CryptosR_Us/status/2089406150467100792/video/1?s=46
1 · Reply